Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias

• Sang-Guk Lee,
• Sun Young Cho,
• Min Jin Kim,
• Seung Hwan Oh,
• Eun Hae Cho,
• Sanggyu Lee,
• Eun Jung Baek,
• Jung Hye Choi,
• Stefan K. Bohlander,
• Laurence Lode,
• Steven Richebourg,
• Hwi-Joong Yoon,
• Rolf Marschalek,
• Claus Meyer,
• Tae Sung Park

Affiliations

Sang-Guk Lee

Department of Laboratory Medicine, Armed Forces Capital Hospital, Seongnam, Korea;Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea

Sun Young Cho

Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea

Min Jin Kim

Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea

Seung Hwan Oh

Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea

Eun Hae Cho

Greencross Reference Laboratory, Yongin, Korea

Sanggyu Lee

School of Life Science and Biotechnology, Kyungpook National University, Daegu, Korea

Eun Jung Baek

Department of Laboratory Medicine, Hanyang University Kuri Hospital, Kuri, Korea

Jung Hye Choi

Department of Internal Medicine, Hanyang University Kuri Hospital, Kuri, Korea

Stefan K. Bohlander

Laboratory of Leukemia Diagnostics, Department of Medicine III, University of Munich Hospital, Munich, Germany

Laurence Lode

Service de Biologie/Hématologie, CHU, Nantes, France

Steven Richebourg

Service de Biologie/Hématologie, CHU, Nantes, France

Hwi-Joong Yoon

Department of Hematology-Oncology, School of Medicine, Kyung Hee University, Seoul, Korea

Rolf Marschalek

Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia, Goethe-University of Frankfurt, Germany

Claus Meyer

Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia, Goethe-University of Frankfurt, Germany

Tae Sung Park

Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea